Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-05-01 Tax Withholding(A) | 2024-10-31 5:57 pm | N/A N/A | JOHNSON & JOHNSON | JNJ | REED JOHN C EVP, Innovative Medicine, R&D | 10,984 | $144.59 | 65,087 (Direct) | View |
| 2024-05-01 Exercise(A) | 2024-10-31 5:57 pm | N/A N/A | JOHNSON & JOHNSON | JNJ | REED JOHN C EVP, Innovative Medicine, R&D | 25,255 | $0 | 65,087 (Direct) | View |
| 2024-05-01 Tax Withholding | 2024-05-03 4:31 pm | N/A N/A | JOHNSON & JOHNSON | JNJ | REED JOHN C EVP, Innovative Medicine, R&D | 10,984 | $144.59 | 65,087 (Direct) | View |
| 2024-05-01 Exercise | 2024-05-03 4:31 pm | N/A N/A | JOHNSON & JOHNSON | JNJ | REED JOHN C EVP, Innovative Medicine, R&D | 22,255 | $0 | 65,087 (Direct) | View |
| 2024-02-15 Option Award | 2024-02-20 5:55 pm | N/A 2034-02-15 | JOHNSON & JOHNSON | JNJ | REED JOHN C EVP, Innovative Medicine, R&D | 69,211 | $0 | 69,211 (Direct) | View |
| 2023-05-01 Option Award | 2023-05-02 5:21 pm | N/A N/A | JOHNSON & JOHNSON | JNJ | REED JOHN C EVP, Pharmaceuticals R&D | 75,765 | $0 | 75,765 (Direct) | View |
Ownership | 2023-04-13 5:10 pm | N/A N/A | JOHNSON & JOHNSON | JNJ | REED JOHN C EVP, Pharmaceuticals R&D | 0 | $0 | 306 (Direct) | View |